Mechanism-based inhibition of cancer metastasis with (-)-epigallocatechin gallate

Biochemical and Biophysical Research Communications

Volumn 443, Issue 1, 2014, Pages 1-6

  Takahashi, Atsushi ^a,b,c   Watanabe, Tatsuro ^a   Mondal, Anupom ^a   Suzuki, Kaori ^a   Kurusu Kanno, Miki ^a   Li, Zhenghao ^a,b   Yamazaki, Takashi ^a,b   Fujiki, Hirota ^a   Suganuma, Masami ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b SAITAMA UNIVERSITY   (Japan)

^c Saitama Prefectural Agriculture and Forestry Research Center   (Japan)

Author keywords

AFM; Cell migration; EMT; Green tea catechin; M CD; Vimentin

Indexed keywords

CHOLESTEROL; EPIGALLOCATECHIN GALLATE; METHYL BETA CYCLODEXTRIN; VIMENTIN;

ANIMAL CELL; ARTICLE; ASSAY; ATOMIC FORCE MICROSCOPY; CANCER CELL; CANCER CELL CULTURE; CELL MEMBRANE; CELL MOTILITY; CONTROLLED STUDY; ELASTICITY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL LINE; MEMBRANE STRUCTURE; METASTASIS; MOUSE; NON SMALL CELL LUNG CANCER CELL LINE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; WOUND HEALING;

MUS;

AFM; CELL MIGRATION; EMT; GREEN TEA CATECHIN; MΒCD; VIMENTIN;

ANIMALS; ANTINEOPLASTIC AGENTS; BETA-CYCLODEXTRINS; CATECHIN; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CHOLESTEROL; ELASTIC MODULUS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; MICE; MICROSCOPY, ATOMIC FORCE; NEOPLASM METASTASIS; TRANSCRIPTION FACTORS; VIMENTIN;

EID: 84890858050     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.094     Document Type: Article

References (27)

1. Shimizu M., Fukutomi Y., Ninomiya M., Nagura K., Kato T., Araki H., Suganuma M., Fujiki H., Moriwaki H. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 2008, 17:3020-3025.
2. Fujiki H., Imai K., Nakachi K., Shimizu M., Moriwaki H., Suganuma M. Challenging the effectiveness of green tea in primary and tertiary cancer prevention. J. Cancer Res. Clin. Oncol. 2012, 138:1259-1270.
3. Taniguchi S., Fujiki H., Kobayashi H., Go H., Miyado K., Sadano H., Shimokawa R. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines. Cancer Lett. 1992, 65:51-54.
4. Cross S.E., Jin Y.S., Lu Q.Y., Rao J., Gimzewski J.K. Green tea extract selectively targets nanomechanics of live metastatic cancer cells. Nanotechnology 2011, 22:215101. 10.1088/0957-4484/22/21/215101.
5. Lekka M., Laidler P., Gil D., Lekki J., Stachura Z., Hrynkiewicz A.Z. Elasticity of normal and cancerous human bladder cells studied by scanning force microscopy. Eur. Biophys. J. 1999, 28:312-316.
6. Cross S.E., Jin Y.S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2007, 2:780-783.
7. Watanabe T., Kuramochi H., Takahashi A., Imai K., Katsuta N., Nakayama T., Fujiki H., Suganuma M. Higher cell stiffness indicating lower metastatic potential in B16 melanoma cell variants and in (-)-epigallocatechin gallate-treated cells. J. Cancer Res. Clin. Oncol. 2012, 138:859-866.
8. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
9. Weinberg R.A. Moving out: invasion and metastasis. The Biology of Cancer, Garland Science 2007, 587-654. Taylor & Francis Group LLC, New York. R.A. Weinberg (Ed.).
10. Suganuma M. Cell stiffness as a new indicator of diagnosis for human lung cancer cells and their metastasis. Am. Assoc. Cancer Res. Annu. Meet. 2013, 2013:2640A.
11. Swaminathan V., Mythreye K., O'Brien E.T., Berchuck A., Blobe G.C., Superfine R. Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res. 2011, 71:5075-5080.
12. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. J. Clin. Invest. 2009, 119:1429-1437.
13. Menon S., Beningo K.A. Cancer cell invasion is enhanced by applied mechanical stimulation. PLoS ONE 2011, 6:e17277.
14. Gilles C., Polette M., Zahm J.M., Tournier J.M., Volders L., Foidart J.M., Birembaut P. Vimentin contributes to human mammary epithelial cell migration. J. Cell Sci. 1999, 112:4615-4625.
15. Yancey P.G., Rodrigueza W.V., Kilsdonk E.P., Stoudt G.W., Johnson W.J., Phillips M.C., Rothblat G.H. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 1996, 271:16026-16034.
16. Fujiki H., Okuda T. (-)-Epigallocatechin gallate. Drugs Future 1992, 17:462-464.
17. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007, 2:329-333.
18. Levy R., Maaloum M. Measuring the spring constant of atomic force microscope cantilevers: thermal fluctuations and other methods. Nanotechnology 2002, 13:33-37.
19. Trickey W.R., Baaijens F.P., Laursen T.A., Alexopoulos L.G., Guilak F. Determination of the Poisson's ratio of the cell: recovery properties of chondrocytes after release from complete micropipette aspiration. J. Biomech. 2006, 39:78-87.
20. Watanabe T., Hirano K., Takahashi A., Yamaguchi K., Beppu M., Fujiki H., Suganuma M. Nucleolin on the cell surface as a new molecular target for gastric cancer treatment. Biol. Pharm. Bull. 2010, 33:796-803.
21. Suganuma M., Yamaguchi K., Ono Y., Matsumoto H., Hayashi T., Ogawa T., Imai K., Kuzuhara T., Nishizono A., Fujiki H. TNF-α inducing protein, a carcinogenic factor secreted from H. pylori, enters gastric cancer cells. Int. J. Cancer 2008, 123:117-122.
22. Yoshizawa S., Horiuchi T., Suganuma M., Nishiwaki S., Yatsunami J., Okabe S., Okuda T., Muto Y., Troll W., Fujiki H. Penta-O-galloyl-β-d-glucose and (-)-epigallocatechin gallate. ACS Symp. Ser. 1992, 507:316-325.
23. Fujiki H. Green tea: health benefits as cancer preventive for humans. Chem. Rec. 2005, 5:119-132.
24. Adachi S., Nagao T., Ingolfsson H.I., Maxfield F.R., Andersen O.S., Kopelovich L., Weinstein I.B. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res. 2007, 67:6493-6501.
25. Wu Y., McEwen G.D., Harihar S., Baker S.M., DeWald D.B., Zhou A. BRMS1 expression alters the ultrastructural, biomechanical and biochemical properties of MDA-MB-435 human breast carcinoma cells: an AFM and Raman microspectroscopy study. Cancer Lett. 2010, 293:82-91.
26. Murai T., Maruyama Y., Mio K., Nishiyama H., Suga M., Sato C. Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J. Biol. Chem. 2011, 286:1999-2007.
27. Kawashima M., Iwamoto N., Kawaguchi-Sakita N., Sugimoto M., Ueno T., Mikami Y., Terasawa K., Sato T.A., Tanaka K., Shimizu K., Toi M. High-resolution imaging mass spectrometry reveals detailed spatial distribution of phosphatidylinositols in human breast cancer. Cancer Sci. 2013, 104:1372-1379.